Spinal cages built to fuse bone: can they steady a slipping spine?
NCT ID NCT03928041
First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time
Summary
Researchers are studying a spinal implant called the EVOS Lumbar Interbody System, which uses PEEK-OPTIMA HA enhanced cages, in adults with degenerative disc disease or grade 1 spondylolisthesis in the lower back. The study follows participants who receive the device during spinal fusion surgery to see how well bone grows between the vertebrae and how much their back and leg pain and quality of life change. About 22 people will take part, and the study measures fusion using imaging scans and pain using standard questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- PEEK-OPTIMA HA enhanced interbody cage, a spinal fusion implant
- What this could lead to
- If the cages perform well, they could offer a reliable option for fusing the lumbar spine and reducing back and leg pain in people with degenerative disc disease or mild spondylolisthesis.
- What could go wrong
- This is a small, single-arm study with no comparison group, so results may not reflect how the device performs in a broader population. Spinal fusion surgery carries risks such as infection, nerve injury, and failure of the bone to fuse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
22 people
The number who actually took part.
- Started
-
Jun 2019
- Finished
-
Sep 2023
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Is the subject aged 18 years of age or older and skeletally mature? * Does the subject have a primary diagnosis of symptomatic degenerative disc disease (DDD) or symptomatic degenerative disc disease (DDD) with spondylolisthesis (Grade 1) at one or two contiguous levels from L2 to S1? * Does the subject have discogenic back pain with degeneration of the disc confirmed by medical history, radiographic examination and MRI (MRI must be obtained within the 6 months prior to subject surgery and radiographs obtained within 3 months prior to subject surgery)? * Is the subject judged by the Investigator to be suitable for transforaminal lumbar interbody fusion (TLIF) surgery based on their medical history? * Is the subject indicated for surgical treatment with the EVOS Lumbar Interbody System with autologous bone graft? * Has the subject completed at least 6 months of conservative non-operative treatment without obtaining adequate symptomatic relief? * If the subject is female and of childbearing age, do they have a negative pregnancy test (by Beta HCG qualitative analysis), or do they have a history of a surgical sterilisation, or a history of no menses in the past twelve months? * Is the subject, in the opinion of the Investigator, able to understand this clinical study, co-operate with the procedures and are they willing to return to the hospital for all the required post-operative follow-ups? * Is the subject able to give voluntary, written informed consent to participate in this clinical study and from whom consent has been obtained? Exclusion Criteria: * Has the subject undergone previous spinal surgery at the affected disc level(s), excluding discectomy and laminectomy procedures? * Does the subject have evidence of tumour and/or malignant disease with resultant life expectancy of less than two years? * Does the subject have known osteoporosis or severe osteopenia as determined by the Investigator? * Does the subject have rheumatoid arthritis, ankylosing spondylitis or are they immunocompromised? * Does the subject have a known allergy to the material used in the instrumentation? * Does the subject have evidence of an active infection and/or do they have any condition that would compromise their participation and follow-up in this clinical study? * Is the subject receiving any drug treatment that may affect bone metabolism? * If the subject is female, are they pregnant or lactating? * Is the subject a current smoker, or have they stopped smoking less than 6 months ago? * Is the subject a known drug or alcohol abuser or do they have a baseline opioid use greater than 30 mg of morphine equivalent/day or do they have psychological disorders that could affect follow-up care or treatment outcomes? * Is the subject currently enrolled in a clinical study?
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Degenerative disc disease lumbar are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OrthoCarolina Research Institute
Charlotte, North Carolina, 28207, United States
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.